Buy or sell KSQ Therapeutics stock pre IPO via an EquityZen fund

EquityZen is a marketplace for shares of proven pre IPO tech companies

KSQ Therapeutics Stock

Drug discovery company

Founded

2015

Notable Investors

Headquarters

Cambridge MA, US

Total Funding

$156M

About KSQ Therapeutics Stock

KSQ Therapeutics states that it is pioneering High-Confidence Drug Development: a fundamentally new approach to R&D where the majority of the de-risking work is done prior to the generation of therapeutic drug candidates. Powered by a proprietary CRISPRomics™ drug discovery engine, their team has elucidated the function that each human gene plays in multiple diseases, providing a more comprehensive understanding of disease biology. The quality of these insights enables their scientists to identify and validate high-confidence, patient-tailored drug targets and then focus their collective efforts on the development of medicines with the greatest potential to impact the lives of patients. KSQ has initiated a pipeline of preclinical discovery programs and was founded in 2015.

Funding History

October 2017$76.0M
September 2018$80.0M

Management

CSO

Frank Stegmeier

Founder

David Sabatini

VP, Head of Chemistry and Drug Design

René M. Lemieux

Sr. Director, Head of Corporate Development

John Trzupek

Managing Director & CEO

David Meeker

Other Companies

Logo
Adaptive Biotechnologies

DNA sequencing for cancer therapy & research

Logo
CRISPR Therapeutics

CRISPR Therapeutics is focused on the development of transformative medicines using its proprietary CRISPR/Cas9 gene-editing platform.

Logo
Genapsys

GenapSys develops DNA sequencing technologies and systems for applied genomic testing and medical sequencing.

Logo
Kaleido BioSciences

Kaleido BioSciences is a company working to design and analyze the microbiome system and provide adaptive solutions.

EquityZen does not have an affiliation with, formal relationship with, or endorsement from KSQ Therapeutics or any companies feature above. This profile is based on publicly available information and is intended to be informative in nature.

Some data provided by Crunchbase

Join 70K+ Investors and Shareholders

On our trusted digital marketplace for private companies

EquityZen Recognized As:

Logo

Logo